| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/25/2003 | US20030235590 Hepatitis B virus (hbv) purified in presence of cysteine |
| 12/25/2003 | US20030235584 Method for preparing anti-MIF antibodies |
| 12/25/2003 | US20030235579 Anti-equine Fc epsilon receptor alpha chain antibodies and method to detect IgE |
| 12/25/2003 | US20030235558 Contacting a compound with a sample containing p62 and ubiquitin, determining level of p62/ubiquitin binding under normal conditions and in the presence of the compound and comparing the two levels |
| 12/25/2003 | US20030235557 Administering two viral vectors containing an immunogenic portion of a wilms' tumor (wt1) polynucleotide operably linked to an expression control sequence |
| 12/25/2003 | US20030235535 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions |
| 12/25/2003 | US20030235532 A radiotherapy by administering a labeled iodine to a mammal, having taken a transgene and a DNA sequence encoding a sodium-iodide symporter before; gene therapy, chemiluminescence |
| 12/24/2003 | WO2003107249A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 12/24/2003 | WO2003106972A2 Multiple domain tdf-related compounds and analogs thereof |
| 12/24/2003 | WO2003106970A2 P27 prevents cellular migration |
| 12/24/2003 | WO2003106713A1 Antisense modulation of stati expression |
| 12/24/2003 | WO2003106694A2 Rapid methods for assessing therapeutic activity using animals expressing constitutively active g protein-coupled receptors |
| 12/24/2003 | WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | WO2003106683A1 Novel screening method |
| 12/24/2003 | WO2003106674A2 Means and methods for regulating gene expression |
| 12/24/2003 | WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | WO2003106657A2 Wise/sost nucleic acid sequences and amino acid sequences |
| 12/24/2003 | WO2003106656A2 Single domain tdf-related compounds and analogs thereof |
| 12/24/2003 | WO2003106650A2 Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 12/24/2003 | WO2003106648A2 Compositions and methods relating to breast specific genes and proteins |
| 12/24/2003 | WO2003106634A2 Vectors for expression of hml-2 polypeptides |
| 12/24/2003 | WO2003106633A2 Method to increase isoflavonoid levels in plants and plants producing increased levels of isoflavonoids |
| 12/24/2003 | WO2003106632A2 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 12/24/2003 | WO2003106616A2 MEMBRANE-ANCHORED beta2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES |
| 12/24/2003 | WO2003106615A2 Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation |
| 12/24/2003 | WO2003106501A1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 12/24/2003 | WO2003106496A1 Antibodies, peptides and vaccines against hiv-1 virus |
| 12/24/2003 | WO2003106494A1 A human collagen-like protein and the method of producing it |
| 12/24/2003 | WO2003106492A1 Marker for stem cells and its use |
| 12/24/2003 | WO2003106491A2 Cell penetrating peptides |
| 12/24/2003 | WO2003106490A1 A fusion protein comprising a cellulose binding domain |
| 12/24/2003 | WO2003106489A1 Novel neuropeptide analogs and use thereof |
| 12/24/2003 | WO2003106488A2 Novel antagonists of cxcr3-binding cxc chemokines |
| 12/24/2003 | WO2003106487A1 Immunogenic conjugates |
| 12/24/2003 | WO2003106486A1 Vegetable protein preparations and use thereof |
| 12/24/2003 | WO2003106485A1 Method for the production of protamine |
| 12/24/2003 | WO2003106479A2 Pokeweed antiviral protein polypeptides with antiviral activity |
| 12/24/2003 | WO2003105892A1 Neuroendocrine marker for cancer and method for producing same |
| 12/24/2003 | WO2003105890A2 Vaccine composition |
| 12/24/2003 | WO2003105887A1 Inhibition of t cell activation by butyrophilin 4 or b7-l1 |
| 12/24/2003 | WO2003105886A2 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation |
| 12/24/2003 | WO2003105880A1 Peptides selectively lethal to malignant and transformed mammalian cells |
| 12/24/2003 | WO2003105879A1 Compositions and methods for preventing, treating and diagnosing diabetes |
| 12/24/2003 | WO2003105814A1 In vivo imaging of apoptosis |
| 12/24/2003 | WO2003105773A2 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets: |
| 12/24/2003 | WO2003105772A2 Analogs of parathyroid hormone and pth-related protein as bone anabolic agents |
| 12/24/2003 | WO2003105763A2 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 12/24/2003 | WO2003105758A2 Cancer-linked gene as target for chemotherapy |
| 12/24/2003 | WO2003105665A2 Epstein-barr virus-specific immunization |
| 12/24/2003 | WO2003091274A3 Use of alpha-s2 casein precursor-derived peptided |
| 12/24/2003 | WO2003089465A3 Crystals structure of the mouse apoptosis-inducing factor aif and applications thereof |
| 12/24/2003 | WO2003083113A3 Growth regulating proteins |
| 12/24/2003 | WO2003078458A3 Tap-70, a novel marker for epithelial tumors |
| 12/24/2003 | WO2003078455A3 Virus like particle from papillomavirus and their use in vaccine |
| 12/24/2003 | WO2003077942A3 Virus-like particles of human papillomavirus |
| 12/24/2003 | WO2003076464A3 Mutagenesis of aspergillus fungi and identification of genes essential for growth |
| 12/24/2003 | WO2003075647A3 Method and system for in vivo analysis of developmental processes |
| 12/24/2003 | WO2003075014A3 Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11 |
| 12/24/2003 | WO2003073097A9 Methods for isolating ligands e.g. t cell epitopes |
| 12/24/2003 | WO2003072755A3 Transgenic zebrafish models for thrombosis |
| 12/24/2003 | WO2003072706A3 Nucleic acid molecules encoding proteins essential for fungal growth and development and uses thereof |
| 12/24/2003 | WO2003072598A3 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases |
| 12/24/2003 | WO2003070770A3 Engineered human kunitz-type protease inhibitor |
| 12/24/2003 | WO2003070766A3 A transducer of mas signalling |
| 12/24/2003 | WO2003068925A3 Production of a protein delivery system for in vivo therapeutic treatment |
| 12/24/2003 | WO2003066845A3 Bacteriophage lysin |
| 12/24/2003 | WO2003066097A3 A novel target to inhibit angiogenesis |
| 12/24/2003 | WO2003066094A3 Hepatitis b vaccines |
| 12/24/2003 | WO2003064681A3 Assays |
| 12/24/2003 | WO2003062431A3 Production of epi-hne-4 comprising reduction of improperly processed form |
| 12/24/2003 | WO2003059936A3 Phytophthora Infestans CDC 14 Phosphatase Gene, Protein and Methods of Use |
| 12/24/2003 | WO2003057917A3 An isolated nucleotide sequence responsible for the tomato dark green (dg) mutation and uses thereof |
| 12/24/2003 | WO2003055917A3 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 12/24/2003 | WO2003045429A3 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 12/24/2003 | WO2003040181A3 Genes from the corynebacterium glutamicum coding for regulatory proteins |
| 12/24/2003 | WO2003039454A3 Beta-secretase inhibitors and methods of use |
| 12/24/2003 | WO2003039226A3 Front opening body armor |
| 12/24/2003 | WO2003038095A3 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents |
| 12/24/2003 | WO2003037920A3 Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regeneration |
| 12/24/2003 | WO2003037267A8 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/24/2003 | WO2003033661A8 Methods of using 279, a human g protein-coupled receptor |
| 12/24/2003 | WO2003027322A3 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 12/24/2003 | WO2003022990A3 Production of fusion proteins and use for identifying binding molecules |
| 12/24/2003 | WO2003018626A3 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
| 12/24/2003 | WO2003017934A3 Folded monomers of the hiv-1 protease and methods of their use |
| 12/24/2003 | WO2003016329A3 Glycoconjugates of sialic acid derivates, methods for their production and use thereof |
| 12/24/2003 | WO2003014376A3 Sugar and lipid metabolism regulators in plants iii |
| 12/24/2003 | WO2003014353A3 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 12/24/2003 | WO2003014352A3 Nucleic acids for aminocoumarin biosynthesis |
| 12/24/2003 | WO2003014293A3 Novel polypeptide analogs and fusions and their methods of use |
| 12/24/2003 | WO2003014078A3 Muc7d1 peptides as antifungal and antibacterial agents |
| 12/24/2003 | WO2003010327A3 Novel proteins and nucleic acids encoding same |
| 12/24/2003 | WO2003006491A3 Peptide-based compounds for targeting intergin receptors |
| 12/24/2003 | WO2003005033A3 Carcinoma-related peptides |
| 12/24/2003 | WO2003002061B1 Compositions and methods for treating atherosclerosis |
| 12/24/2003 | WO2003000905A3 Identification and characterization of plant genes |
| 12/24/2003 | WO2003000888A3 Method for separating bacterial cells and cell components |
| 12/24/2003 | WO2002102990A8 Fibroblast growth factor and nucleic acid encoding same |
| 12/24/2003 | WO2002102321A3 Novel proteins and nucleic acids encoding same |
| 12/24/2003 | WO2002096929A3 Polypeptides reacting with hcv-infected patients' antibodies and uses |